From 4 to 6 June, Milan will host the 46th Congress of ANMCO, the Italian National Association of Hospital Cardiologists. Prof. Michele Gulizia, ANMCO President, and Prof. Luigi Tavazzi, Member of the Study Group on Surveys and on Acute Heart Failure of the Association on Heart Failure of the ESC and Chairman of the Regulatory Subcommittee of the Committeee on European Affairs of the ESC, have invited EUROTRACS to participate in the Congress presenting the first results. The presentation "Gestione della sindrome coronarica acuta: benchmarking degli ospedali e analisi costo-efficacia. Risultati dei progetti EURHOBOP e EUROTRACS (ACS management: hospital benchmarking and cost-effectiveness analysis) will be made by Marina Torre, ISS, Rome during the Main Session "CONVENTION UTIC: È IL MOMENTO DI PASSARE ALLA UACC?" of Saturday 6 June.

Click here to see the final program of the Congress.


To share the results obtained and highlight the strategies to promote their dissemination through the partners’ active at national and EU level targeting the stakeholders interested in ACS management (policy makers, general population, health operators, administration, patients). These are the aims of the final workshop to be held at the IMIM facilities in the Barcelona Biomedical Research Park (PRBB) Ramon y Cajal room on 7 and 8 May 2015. The agenda foresees three work sessions on the first day presenting the Dissemination strategies, and the results achieved in “Estimating the number of CAD events prevented at 10 year by population interventions” and in “Estimating the procedure‐associated in‐hospital mortality and procedure cost in ACS”. The second day is organized in three sessions dedicated, respectively, to the Evaluation of the project and to show the findings obtained by performing “Cost‐effectiveness analysis of decreasing CAD incidence by reducing population risk factor prevalence” and “Cost effectiveness analysis of ACS procedures that lower in‐hospital fatality in patients older than 34 year”.
Anne‐Marie Yazbeck, Agency Officer at CHAFEA ‐ The Consumers, Health, Agriculture and Food Executive and Jaume Marrugat, EUROTRACS Project Coordinator, will welcome and close the workshop.

Participation is limited to members of the project working group, but the investigators would be glad to consider a personalized invitation to interested stakeholders and general public.
Please contact Yolanda Ferrer in such case (

Download the final workshop programme


The benchmarking system, developed in the EURHOBOP project led by Jaume Marrugat of IMIM – Hospital del Mar Medical Research Institute (Barcelona, Spain), has just been published in the International Journal of Cardiology, one of the top Cardiology scientific journals. This is the first international system that allows the assessment of patient management in acute myocardial infarction (AMI) and Percutaneous Coronary Intervention (PCI) by comparing in-hospital mortality among hospitals with similar characteristics and similar patient profile. This comparison can be done by cardiologists, hospital managers or other healthcare professionals, provided that a sample of acute coronary syndrome (ACS) patients is available. The models were conceived and developed in their first version as a result of the pilot phase of the EUPHORIC project ( and, thanks to the important collaborative job of all the participating partners (, further developed and finalized in the EURHOBOP project, with a cohort of 15,170 ACS patients. Then, they were externally validated, with a cohort of 55,955 European ACS patients, showing good discrimination at patient level and acceptable accuracy at hospital level. Previously, such models had only been available for the US or single European countries, thus lacking the possibility of a cross-European performance assessment. This lack is now covered by the EURHOBOP benchmarking system, a simple and reliable tool that uses multilevel logistic regression to compare in-hospital mortality rates in AMI and PCI by taking into account the country, and hospital- and patient-level variables. The article “R. Degano I, Subirana I, Torre M, Grau M, Vila J, Fusco D, Kirchberger I, Ferrieres J, Malmivaara A, Azevedo A, Meisinger C, Bongard V, Farmakis D, Davoli M, Häkkinen U, Araújo C, Lekakis J, Elosua R, Marrugat J, on behalf of the EURHOBOP investigators. A European benchmarking system to evaluate in-hospital mortality rates in acute coronary syndrome: The EURHOBOP project. International Journal of Cardiology. 2015. doi:10.1016/j.ijcard.2015.01.019. [Epub ahead of print]" is available at the following address: Click here to register and be allowed to use the developed functions.


On the 12-13 February 2015, the “Chronic Diseases and Healthy Ageing (CD-HA) workshop. Addressing chronic diseases and healthy ageing issues in 8 countries: BE, F, DE, IE, NL, UK, LU, ES” is going to be held in The Hague (NL), organized by CHAFEA in collaboration with DG-SANTE. To widely disseminate results of the second EU Health Programme at EU, national, regional and local levels, CHAFEA collaborates with the National Focal Points to organize events that are hosted by different EU countries.
Aims of this Workshop are to share the knowledge acquired through the CD-HA actions funded under the second Health Programme 2008-2013, to show how the outcomes of the projects can be used to build the evidence base on improving quality of life, efficiencies and resources management in health systems, and to develop future recommendations for policy development.
Results of over 10 actions will be presented in line with the EU-wide understanding of chronic diseases and healthy ageing. EUROTRACS will contribute to the discussion about Cost-effectiveness of health intervention (Session 4 – More efficient healthcare delivery better quality of care presented by Jaume Marrugat, IMIM, Barcelona) and to the Panel 2: So what to do on EU level?
Target audience of the Workshop are experts on chronic diseases and healthy ageing, policy-makers, and health professionals.
To know more about this event, click here to register and download the programme.


The Faculty of Medicine of the University of Porto leaded by Ana Azevedo, in the context of the Eurhobop project, has published in the journal European Journal of Preventive Cardiology an interesting study that analyses age and sex inequalities in the prescription of evidence-based pharmacological therapy following an acute coronary syndrome (ACS) in Portugal. The study shows that sex had no significant effect on treatment prescription; regarding the age, the recommended therapies were substantially underprescribed in older patients. Overall, the vast majority of patients were discharged on evidence-based secondary preventive medications, but only half received a 5-drug combination.

The article “Pereira M, Araújo C, Dias P, Lunet N, Subirana I, Marrugat J, Capewell S, Bennett K, Azevedo A. Age and sex inequalities in the prescription of evidence-based pharmacological therapy following an acute coronary syndrome in Portugal: the EURHOBOP study. European Journal of Preventive Cardiology published online 20 June 2013 doi: 10.1177/2047487313494580. [Epub ahead of print]" is available at the following address:


The Research and Prevention on Cardiovascular Diseases group of Toulouse leaded by Jean Ferrières, in the context of the Eurhobop project, has recently published in the journal Heart an interesting study that highlights the differences in in-hospital mortality rates in patients admitted in 53 hospitals from Finland, France, Germany, Greece, Portugal and Spain. The study shows that these differences are partly explained by differences in baseline characteristics and in clinical management and are highly impacted by differences in pre-hospital patient management  directly related to healthcare system organization.

The article “André R, Bongard V, Elosua R, Kirchberger I, Farmakis D, Häkkinen U, Fusco D, Torre M, Garel P, Araújo C, Meisinger C, Lekakis J, Malmivaara A, Dovali M, Pereira M, Marrugat J, Ferrières J. International differences in acute coronary syndrome patients' baseline characteristics, clinical management and outcomes in Western Europe: the EURHOBOP study. Heart. 2014 May 1. doi: 10.1136/heartjnl-2013-305196. [Epub ahead of print]" is available at the following address:


The cardiovascular research group at IMIM has recently published in the Journal of Epidemiology and Community Health the description of a mathematical system to predict the 10-year number of coronary artery population events in Girona, Catalonia and Spain. The methods described and their validation with real life data, are the basis for our EUROTRACS project. This system permits to analyse the impact that some interventions aimed at reducing or spontaneous changes in cardiovascular risk factor prevalence would have at 10 years in terms of the expected number of CAD events and incidence. Thanks to the very stimulating brainstorming of the first months of activity in EUROTRACS, the development of this concept and the data publication were accelerated. We are pleased to consider this paper as the first scientific contribution of EUROTRACS.

The article Grau M, Subirana I, Vila J, Elosua R, Ramos R, Sala J, Dégano IR, Tresserras R, Bielsa O, Marrugat J. Validation of a population coronary disease predictive system: the CASSANDRA model. J Epidemiol Community Health. 2014 Mar 11. doi: 10.1136/jech-2013-203516. [Epub ahead of print] is available at the following address: